Merck & Co., Inc. Selling, General and Administrative Expense
Merck & Co., Inc. (MRK) reported Selling, General and Administrative Expense of $2.90 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-07
- Merck & Co., Inc. selling, general and administrative expense for the quarter ending 2026-06-30 was $2.90B, a 9.63% increase year-over-year.
- Merck & Co., Inc. selling, general and administrative expense for the quarter ending 2026-03-31 was $2.70B, a 5.80% increase year-over-year.
- Merck & Co., Inc. selling, general and administrative expense for the quarter ending 2025-12-31 was $2.90B, a 1.19% increase year-over-year.
- Merck & Co., Inc. selling, general and administrative expense for the quarter ending 2025-09-30 was $2.63B, a 3.59% decline year-over-year.
- Merck & Co., Inc. selling, general and administrative expense for fiscal 2025 was $10.73B, a 0.77% decline from fiscal 2024.
- Merck & Co., Inc. selling, general and administrative expense for fiscal 2024 was $10.82B, a 2.97% increase from fiscal 2023.
- Merck & Co., Inc. selling, general and administrative expense for fiscal 2023 was $10.50B, a 4.60% increase from fiscal 2022.
- Merck & Co., Inc. selling, general and administrative expense for fiscal 2022 was $10.04B, a 4.24% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.90B 10-Q · filed 2026-08-07 | $5.60B 10-Q · filed 2026-08-07 | $8.50B derived: sum of 3 quarters · filed 2026-08-07 | $11.13B derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | $2.70B 10-Q · filed 2026-05-04 | $5.60B derived: sum of 2 quarters · filed 2026-05-04 | $8.23B derived: sum of 3 quarters · filed 2026-05-04 | $10.88B derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-12-31 | $2.90B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $5.53B derived: sum of 2 quarters · filed 2026-02-24 | $8.18B derived: sum of 3 quarters · filed 2026-08-07 | $10.73B 10-K · filed 2026-02-24 | ||||
| 2025-09-30 | $2.63B 10-Q · filed 2025-11-05 | $5.28B derived: sum of 2 quarters · filed 2026-08-07 | $7.83B 10-Q · filed 2025-11-05 | $10.70B derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | $2.65B 10-Q · filed 2026-08-07 | $5.20B 10-Q · filed 2026-08-07 | $8.06B derived: sum of 3 quarters · filed 2026-08-07 | $10.80B derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-03-31 | $2.55B 10-Q · filed 2026-05-04 | $5.42B derived: sum of 2 quarters · filed 2026-05-04 | $8.15B derived: sum of 3 quarters · filed 2026-05-04 | $10.89B derived: sum of 4 quarters · filed 2026-05-04 | ||||
| 2024-12-31 | $2.86B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $5.59B derived: sum of 2 quarters · filed 2026-02-24 | $8.33B derived: sum of 3 quarters · filed 2026-02-24 | $10.82B 10-K · filed 2026-02-24 | ||||
| 2024-09-30 | $2.73B 10-Q · filed 2025-11-05 | $5.47B derived: sum of 2 quarters · filed 2025-11-05 | $7.95B 10-Q · filed 2025-11-05 | $10.76B derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-06-30 | $2.74B 10-Q · filed 2025-08-05 | $5.22B 10-Q · filed 2025-08-05 | $8.03B derived: sum of 3 quarters · filed 2026-02-24 | $10.54B derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-03-31 | $2.48B 10-Q · filed 2025-05-02 | $5.29B derived: sum of 2 quarters · filed 2026-02-24 | $7.81B derived: sum of 3 quarters · filed 2026-02-24 | $10.51B derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2023-12-31 | $2.80B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $5.32B derived: sum of 2 quarters · filed 2026-02-24 | $8.03B derived: sum of 3 quarters · filed 2026-02-24 | $10.50B 10-K · filed 2026-02-24 | ||||
| 2023-09-30 | $2.52B 10-Q · filed 2024-11-06 | $5.22B derived: sum of 2 quarters · filed 2024-11-06 | $7.70B 10-Q · filed 2024-11-06 | $10.39B derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-06-30 | $2.70B 10-Q · filed 2024-08-05 | $5.18B 10-Q · filed 2024-08-05 | $7.87B derived: sum of 3 quarters · filed 2025-02-25 | $10.39B derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-03-31 | $2.48B 10-Q · filed 2024-05-03 | $5.17B derived: sum of 2 quarters · filed 2025-02-25 | $7.69B derived: sum of 3 quarters · filed 2025-02-25 | $10.20B derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2022-12-31 | $2.69B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $5.21B derived: sum of 2 quarters · filed 2025-02-25 | $7.72B derived: sum of 3 quarters · filed 2025-02-25 | $10.04B 10-K · filed 2025-02-25 | ||||
| 2022-09-30 | $2.52B 10-Q · filed 2023-11-03 | $5.03B derived: sum of 2 quarters · filed 2023-11-03 | $7.36B 10-Q · filed 2023-11-03 | $10.19B derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2022-06-30 | $2.51B 10-Q · filed 2023-08-07 | $4.83B 10-Q · filed 2023-08-07 | $7.67B derived: sum of 3 quarters · filed 2024-02-26 | $10.00B derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2022-03-31 | $2.32B 10-Q · filed 2023-05-05 | $5.15B derived: sum of 2 quarters · filed 2024-02-26 | $7.49B derived: sum of 3 quarters · filed 2024-02-26 | $9.77B derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2021-12-31 | $2.83B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $5.17B derived: sum of 2 quarters · filed 2024-02-26 | $7.45B derived: sum of 3 quarters · filed 2024-02-26 | $9.63B 10-K · filed 2024-02-26 | ||||
| 2021-09-30 | $2.34B 10-Q · filed 2022-11-03 | $4.62B derived: sum of 2 quarters · filed 2022-11-03 | $6.80B 10-Q · filed 2022-11-03 | $9.42B derived: sum of 4 quarters · filed 2023-02-24 | ||||
| 2021-06-30 | $2.28B 10-Q · filed 2022-08-05 | $4.47B 10-Q · filed 2022-08-05 | $7.09B derived: sum of 3 quarters · filed 2023-02-24 | $9.15B derived: sum of 4 quarters · filed 2023-02-24 | ||||
| 2021-03-31 | $2.19B 10-Q · filed 2022-05-05 | $2.63B 10-Q · filed 2021-05-05 | $4.81B derived: sum of 2 quarters · filed 2023-02-24 | $6.87B derived: sum of 3 quarters · filed 2023-02-24 | $8.95B derived: sum of 4 quarters · filed 2023-02-24 | |||
| 2020-12-31 | $2.62B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $4.68B derived: sum of 2 quarters · filed 2023-02-24 | $6.76B derived: sum of 3 quarters · filed 2023-02-24 | $8.96B 10-K · filed 2023-02-24 | $10.47B 10-K · filed 2021-02-25 | |||
| 2020-09-30 | $2.06B 10-Q · filed 2021-11-05 | $2.45B 10-Q · filed 2020-11-05 | $4.14B derived: sum of 2 quarters · filed 2021-11-05 | $6.34B 10-Q · filed 2021-11-05 | $7.38B 10-Q · filed 2020-11-05 | $8.43B derived: sum of 4 quarters · filed 2022-02-25 | ||
| 2020-06-30 | $2.08B 10-Q · filed 2021-08-09 | $2.38B 10-Q · filed 2020-08-05 | $4.28B 10-Q · filed 2021-08-09 | $4.93B 10-Q · filed 2020-08-05 | $6.37B derived: sum of 3 quarters · filed 2022-02-25 | $8.96B derived: sum of 4 quarters · filed 2022-02-25 | ||
| 2020-03-31 | $2.56B 10-Q · filed 2021-05-05 | $4.28B derived: sum of 2 quarters · filed 2022-02-25 | $6.87B derived: sum of 3 quarters · filed 2022-02-25 | $9.59B derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2019-12-31 | $1.73B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $4.32B derived: sum of 2 quarters · filed 2022-02-25 | $7.03B derived: sum of 3 quarters · filed 2022-02-25 | $9.46B 10-K · filed 2022-02-25 | $10.62B 10-K · filed 2020-02-26 | |||
| 2019-09-30 | $2.59B 10-Q · filed 2020-11-05 | $5.30B derived: sum of 2 quarters · filed 2020-11-05 | $7.73B 10-Q · filed 2020-11-05 | $10.37B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | $2.71B 10-Q · filed 2020-08-05 | $5.14B 10-Q · filed 2020-08-05 | $7.78B derived: sum of 3 quarters · filed 2021-02-25 | $10.22B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | $2.42B 10-Q · filed 2020-05-06 | $5.07B derived: sum of 2 quarters · filed 2021-02-25 | $7.51B derived: sum of 3 quarters · filed 2021-02-25 | $10.02B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | $2.64B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $5.09B derived: sum of 2 quarters · filed 2021-02-25 | $7.59B derived: sum of 3 quarters · filed 2021-02-25 | $10.10B 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | $2.44B 10-Q · filed 2019-11-05 | $4.95B derived: sum of 2 quarters · filed 2019-11-05 | $7.46B 10-Q · filed 2019-11-05 | $10.10B derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2018-06-30 | $2.51B 10-Q · filed 2019-08-06 | $5.02B 10-Q · filed 2019-08-06 | $7.66B derived: sum of 3 quarters · filed 2020-02-26 | $10.12B derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2018-03-31 | $2.51B 10-Q · filed 2019-05-08 | $5.15B derived: sum of 2 quarters · filed 2020-02-26 | $7.61B derived: sum of 3 quarters · filed 2020-02-26 | $10.11B derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2017-12-31 | $2.64B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $5.10B derived: sum of 2 quarters · filed 2020-02-26 | $7.60B derived: sum of 3 quarters · filed 2020-02-26 | $10.07B 10-K · filed 2020-02-26 | $9.83B 10-K · filed 2018-02-27 | |||
| 2017-09-30 | $2.46B 10-Q · filed 2018-11-06 | $2.40B 10-Q · filed 2017-11-07 | $4.96B derived: sum of 2 quarters · filed 2018-11-06 | $7.43B 10-Q · filed 2018-11-06 | $7.25B 10-Q · filed 2017-11-07 | $10.28B derived: sum of 4 quarters · filed 2019-02-27 | ||
| 2017-06-30 | $2.50B 10-Q · filed 2018-08-07 | $2.44B 10-Q · filed 2017-08-08 | $4.97B 10-Q · filed 2018-08-07 | $4.85B 10-Q · filed 2017-08-08 | $7.82B derived: sum of 3 quarters · filed 2019-02-27 | $10.21B derived: sum of 4 quarters · filed 2019-02-27 | ||
| 2017-03-31 | $2.47B 10-Q · filed 2018-05-08 | $2.41B 10-Q · filed 2017-05-09 | $5.32B derived: sum of 2 quarters · filed 2019-02-27 | $7.71B derived: sum of 3 quarters · filed 2019-02-27 | $10.17B derived: sum of 4 quarters · filed 2019-02-27 | |||
| 2016-12-31 | $2.85B derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $5.24B derived: sum of 2 quarters · filed 2019-02-27 | $7.70B derived: sum of 3 quarters · filed 2019-02-27 | $10.02B 10-K · filed 2019-02-27 | $9.76B 10-K · filed 2017-02-28 | |||
| 2016-09-30 | $2.39B 10-Q · filed 2017-11-07 | $4.85B derived: sum of 2 quarters · filed 2017-11-07 | $7.17B 10-Q · filed 2017-11-07 | $9.78B derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-06-30 | $2.46B 10-Q · filed 2017-08-08 | $4.78B 10-Q · filed 2017-08-08 | $7.39B derived: sum of 3 quarters · filed 2018-02-27 | $9.86B derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-03-31 | $2.32B 10-Q · filed 2017-05-09 | $4.93B derived: sum of 2 quarters · filed 2018-02-27 | $7.41B derived: sum of 3 quarters · filed 2018-02-27 | $10.03B derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2015-12-31 | $2.62B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $5.09B derived: sum of 2 quarters · filed 2018-02-27 | $7.71B derived: sum of 3 quarters · filed 2018-02-27 | $10.31B 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | $2.47B 10-Q · filed 2016-11-07 | $5.10B derived: sum of 2 quarters · filed 2016-11-07 | $7.70B 10-Q · filed 2016-11-07 | $10.62B derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-06-30 | $2.62B 10-Q · filed 2016-08-08 | $5.23B 10-Q · filed 2016-08-08 | $8.15B derived: sum of 3 quarters · filed 2017-02-28 | $11.13B derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-03-31 | $2.60B 10-Q · filed 2016-05-09 | $5.53B derived: sum of 2 quarters · filed 2017-02-28 | $8.50B derived: sum of 3 quarters · filed 2017-02-28 | $11.47B derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2014-12-31 | $2.92B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $5.90B derived: sum of 2 quarters · filed 2017-02-28 | $8.87B derived: sum of 3 quarters · filed 2017-02-28 | $11.61B 10-K · filed 2017-02-28 | ||||
| 2014-09-30 | $2.98B 10-Q · filed 2015-11-05 | $5.95B derived: sum of 2 quarters · filed 2015-11-05 | $8.68B 10-Q · filed 2015-11-05 | $11.66B derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-06-30 | $2.97B 10-Q · filed 2015-08-06 | $5.71B 10-Q · filed 2015-08-06 | $8.69B derived: sum of 3 quarters · filed 2016-02-26 | $11.49B derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-03-31 | $2.73B 10-Q · filed 2015-05-07 | $5.72B derived: sum of 2 quarters · filed 2016-02-26 | $8.52B derived: sum of 3 quarters · filed 2016-02-26 | $11.66B derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2013-12-31 | $2.98B derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $5.79B derived: sum of 2 quarters · filed 2016-02-26 | $8.93B derived: sum of 3 quarters · filed 2016-02-26 | $11.91B 10-K · filed 2016-02-26 | ||||
| 2013-09-30 | $2.80B 10-Q · filed 2014-11-10 | $5.94B derived: sum of 2 quarters · filed 2014-11-10 | $8.93B 10-Q · filed 2014-11-10 | $12.32B derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-06-30 | $3.14B 10-Q · filed 2014-08-07 | $6.13B 10-Q · filed 2014-08-07 | $9.52B derived: sum of 3 quarters · filed 2015-02-27 | $12.58B derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-03-31 | $2.99B 10-Q · filed 2014-05-08 | $6.38B derived: sum of 2 quarters · filed 2015-02-27 | $9.44B derived: sum of 3 quarters · filed 2015-02-27 | $12.69B derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2012-12-31 | $3.39B derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $6.45B derived: sum of 2 quarters · filed 2015-02-27 | $9.70B derived: sum of 3 quarters · filed 2015-02-27 | $12.78B 10-K · filed 2015-02-27 | ||||
| 2012-09-30 | $3.06B 10-Q · filed 2013-11-07 | $6.31B derived: sum of 2 quarters · filed 2013-11-07 | $9.39B 10-Q · filed 2013-11-07 | $13.09B derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2012-06-30 | $3.25B 10-Q · filed 2013-08-07 | $6.32B 10-Q · filed 2013-08-07 | $10.03B derived: sum of 3 quarters · filed 2014-02-27 | $13.37B derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2012-03-31 | $3.07B 10-Q · filed 2013-05-09 | $6.78B derived: sum of 2 quarters · filed 2014-02-27 | $10.12B derived: sum of 3 quarters · filed 2014-02-27 | $13.64B derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2011-12-31 | $3.70B derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $7.04B derived: sum of 2 quarters · filed 2014-02-27 | $10.57B derived: sum of 3 quarters · filed 2014-02-27 | $13.73B 10-K · filed 2014-02-27 | ||||
| 2011-09-30 | $3.34B 10-Q · filed 2012-11-09 | $6.87B derived: sum of 2 quarters · filed 2012-11-09 | $10.03B 10-Q · filed 2012-11-09 | $13.56B derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-06-30 | $3.52B 10-Q · filed 2012-08-07 | $6.69B 10-Q · filed 2012-08-07 | $10.22B derived: sum of 3 quarters · filed 2013-02-28 | $13.42B derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-03-31 | $3.16B 10-Q · filed 2012-05-08 | $6.70B derived: sum of 2 quarters · filed 2013-02-28 | $9.89B derived: sum of 3 quarters · filed 2013-02-28 | $13.07B derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2010-12-31 | $3.54B derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $6.73B derived: sum of 2 quarters · filed 2013-02-28 | $9.90B derived: sum of 3 quarters · filed 2013-02-28 | $13.13B 10-K · filed 2013-02-28 | $13.24B 10-K · filed 2011-02-28 | |||
| 2010-09-30 | $3.19B 10-Q · filed 2011-11-08 | $3.22B 10-Q · filed 2010-11-08 | $6.37B derived: sum of 2 quarters · filed 2011-11-08 | $9.59B 10-Q · filed 2011-11-08 | $9.67B 10-Q · filed 2010-11-08 | $13.04B derived: sum of 4 quarters · filed 2012-02-28 | ||
| 2010-06-30 | $3.17B 10-Q · filed 2011-08-08 | $3.20B 10-Q · filed 2010-08-06 | $6.40B 10-Q · filed 2011-08-08 | $6.45B 10-Q · filed 2010-08-06 | $9.85B derived: sum of 3 quarters · filed 2012-02-28 | $11.58B derived: sum of 4 quarters · filed 2012-02-28 | ||
| 2010-03-31 | $3.22B 10-Q · filed 2011-05-09 | $3.25B 10-Q · filed 2010-05-07 | $6.68B derived: sum of 2 quarters · filed 2012-02-28 | $8.40B derived: sum of 3 quarters · filed 2012-02-28 | $10.13B derived: sum of 4 quarters · filed 2012-02-28 | |||
| 2009-12-31 | $3.46B derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $5.18B derived: sum of 2 quarters · filed 2012-02-28 | $6.91B derived: sum of 3 quarters · filed 2012-02-28 | $8.54B 10-K · filed 2012-02-28 | $8.54B 10-K · filed 2010-03-01 | |||
| 2009-09-30 | $1.73B 10-Q · filed 2010-11-08 | $1.51B 10-Q · filed 2009-10-29 | $3.46B derived: sum of 2 quarters · filed 2010-11-08 | $5.09B 10-Q · filed 2010-11-08 | $4.63B 10-Q · filed 2009-10-29 | $7.26B derived: sum of 4 quarters · filed 2011-02-28 | ||
| 2009-06-30 | $1.73B 10-Q · filed 2010-08-06 | $1.63B 10-Q · filed 2009-07-24 | $3.36B 10-Q · filed 2010-08-06 | $3.12B 10-Q · filed 2009-07-24 | $5.53B derived: sum of 3 quarters · filed 2011-02-28 | $7.19B derived: sum of 4 quarters · filed 2011-02-28 | ||
| 2009-03-31 | $1.63B 10-Q · filed 2010-05-07 | $3.80B derived: sum of 2 quarters · filed 2011-02-28 | $5.46B derived: sum of 3 quarters · filed 2011-02-28 | $7.33B derived: sum of 4 quarters · filed 2011-02-28 | ||||
| 2008-12-31 | $2.17B derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | $3.83B derived: sum of 2 quarters · filed 2011-02-28 | $5.70B derived: sum of 3 quarters · filed 2011-02-28 | $7.38B 10-K · filed 2011-02-28 | ||||
| 2008-09-30 | $1.66B 10-Q · filed 2009-10-29 | $3.53B derived: sum of 2 quarters · filed 2009-10-29 | $5.21B 10-Q · filed 2009-10-29 | |||||
| 2008-06-30 | $1.87B 10-Q · filed 2009-07-24 | $3.55B 10-Q · filed 2009-07-24 | ||||||
| 2007-12-31 | $7.56B 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |